{"entity":{"type":"insider","cik":"0001340034","url":"/insider/0001340034","json_url":"/insider/0001340034.json","name":"mRNA Partners L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":5,"first":"2005-10-06","last":"2005-12-14","span_basis":"filed_date"},"name_variants":[{"name":"mRNA Partners L.P.","source":"filing","n_filings":5,"first_seen":"2005-10-06","last_seen":"2005-12-14"}],"transactions":[{"id":1293760,"accession":"0001012975-05-000402","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-05-000402","line_url":"/filing/0001012975-05-000402","is_derivative":false,"issuer_cik":"0000812121","issuer_name":"CRITICARE SYSTEMS INC /DE/","issuer_ticker":"CMD","issuer_name_source":null,"issuer_url":"/issuer/0000812121","owner_cik":null,"owner_name":"Oxford Bioscience Partners (Bermuda) III Limtied Partnership; OBP Management (Bermuda) III Limited Partnership; Oxford Bioscience Partners (Adjunct) III L.P.; mRNA Fund L.P.; OBP Management III L.P.; OXFORD BIOSCIENCE PARTNERS III LP; WALTON ALAN G; mRNA Partners L.P.; FLEMING JONATHAN","owner_display_name":"Oxford Bioscience Partners (Bermuda) III Limtied Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1749073.0,"shares_display":"1,749,073","price_per_share":4.54,"price_display":"4.54","price_state":"stated","total_value":7940791.42,"total_display":"7,940,791.42","total_whole":"7,940,791","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-12","filed_date":"2005-12-14","scope":"insider","n_lines":4},{"id":1219018,"accession":"0001012975-05-000396","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-05-000396","line_url":"/filing/0001012975-05-000396","is_derivative":false,"issuer_cik":"0000812121","issuer_name":"CRITICARE SYSTEMS INC /DE/","issuer_ticker":"CMD","issuer_name_source":null,"issuer_url":"/issuer/0000812121","owner_cik":null,"owner_name":"BARNES JEFFREY T; WALTON ALAN G; FLEMING JONATHAN; OBP Management (Bermuda) III Limited Partnership; mRNA Fund L.P.; OBP Management III L.P.; mRNA Partners L.P.; Oxford Bioscience Partners (Adjunct) III L.P.; Oxford Bioscience Partners (Bermuda) III Limtied Partnership; OXFORD BIOSCIENCE PARTNERS III LP","owner_display_name":"BARNES JEFFREY T","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":4750.0,"total_display":"4,750.00","total_whole":"4,750","shares_owned_after":1401521.0,"shares_owned_after_display":"1,401,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-07","filed_date":"2005-12-08","scope":"insider","n_lines":4},{"id":1257875,"accession":"0001012975-05-000388","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001012975-05-000388","line_url":"/filing/0001012975-05-000388","is_derivative":false,"issuer_cik":"0000812121","issuer_name":"CRITICARE SYSTEMS INC /DE/","issuer_ticker":"CMD","issuer_name_source":null,"issuer_url":"/issuer/0000812121","owner_cik":null,"owner_name":"mRNA Fund L.P.; OBP Management III L.P.; Oxford Bioscience Partners (Bermuda) III Limtied Partnership; OBP Management (Bermuda) III Limited Partnership; mRNA Partners L.P.; FLEMING JONATHAN; WALTON ALAN G; OXFORD BIOSCIENCE PARTNERS III LP; Oxford Bioscience Partners (Adjunct) III L.P.; BARNES JEFFREY T","owner_display_name":"mRNA Fund L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Comon Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":2880.0,"total_display":"2,880.00","total_whole":"2,880","shares_owned_after":131256.0,"shares_owned_after_display":"131,256","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-11-30","filed_date":"2005-12-02","scope":"insider","n_lines":4},{"id":1257871,"accession":"0001012975-05-000388","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-05-000388","line_url":"/filing/0001012975-05-000388","is_derivative":false,"issuer_cik":"0000812121","issuer_name":"CRITICARE SYSTEMS INC /DE/","issuer_ticker":"CMD","issuer_name_source":null,"issuer_url":"/issuer/0000812121","owner_cik":null,"owner_name":"mRNA Fund L.P.; OBP Management III L.P.; Oxford Bioscience Partners (Bermuda) III Limtied Partnership; OBP Management (Bermuda) III Limited Partnership; mRNA Partners L.P.; FLEMING JONATHAN; WALTON ALAN G; OXFORD BIOSCIENCE PARTNERS III LP; Oxford Bioscience Partners (Adjunct) III L.P.; BARNES JEFFREY T","owner_display_name":"mRNA Fund L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":57600.0,"total_display":"57,600.00","total_whole":"57,600","shares_owned_after":1402802.0,"shares_owned_after_display":"1,402,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-29","filed_date":"2005-12-02","scope":"insider","n_lines":4},{"id":1403707,"accession":"0001012975-05-000377","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-05-000377","line_url":"/filing/0001012975-05-000377","is_derivative":false,"issuer_cik":"0000812121","issuer_name":"CRITICARE SYSTEMS INC /DE/","issuer_ticker":"CMD","issuer_name_source":null,"issuer_url":"/issuer/0000812121","owner_cik":null,"owner_name":"mRNA Fund L.P.; OBP Management III L.P.; Oxford Bioscience Partners (Bermuda) III Limtied Partnership; OBP Management (Bermuda) III Limited Partnership; mRNA Partners L.P.; FLEMING JONATHAN; WALTON ALAN G; OXFORD BIOSCIENCE PARTNERS III LP; Oxford Bioscience Partners (Adjunct) III L.P.; BARNES JEFFREY T","owner_display_name":"mRNA Fund L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23600.0,"shares_display":"23,600","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":118000.0,"total_display":"118,000.00","total_whole":"118,000","shares_owned_after":1412414.0,"shares_owned_after_display":"1,412,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-14","filed_date":"2005-11-16","scope":"insider","n_lines":4},{"id":1211122,"accession":"0001012975-05-000341","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001012975-05-000341","line_url":"/filing/0001012975-05-000341","is_derivative":false,"issuer_cik":"0001095787","issuer_name":"AVALON PHARMACEUTICALS INC","issuer_ticker":"AVRX","issuer_name_source":null,"issuer_url":"/issuer/0001095787","owner_cik":null,"owner_name":"Oxford Bioscience Partners (Bermuda) III Limtied Partnership; OBP Management (Bermuda) III Limited Partnership; OXFORD BIOSCIENCE PARTNERS III LP; mRNA Fund L.P.; OBP Management III L.P.; WALTON ALAN G; Oxford Bioscience Partners (Adjunct) III L.P.; BARNES JEFFREY T; mRNA Partners L.P.; FLEMING JONATHAN","owner_display_name":"Oxford Bioscience Partners (Bermuda) III Limtied Partnership","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":181400.0,"shares_display":"181,400","price_per_share":10.5,"price_display":"10.50","price_state":"stated","total_value":1904700.0,"total_display":"1,904,700.00","total_whole":"1,904,700","shares_owned_after":673261.0,"shares_owned_after_display":"673,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-10-04","filed_date":"2005-10-06","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000812121","name":"CRITICARE SYSTEMS INC /DE/","url":"/issuer/0000812121","role":"Ten percent owner","n_filings":4,"first_seen":"2005-11-16","last_seen":"2005-12-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001162192","name":"AVALON PHARMACEUTICALS INC","url":"/issuer/0001162192","role":"Ten percent owner","n_filings":1,"first_seen":"2005-10-06","last_seen":"2005-10-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001340034","retrieved_at":"2026-08-23T12:55:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}